The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BICARA THERAPEUTICS INC | COM | 055477103 | 53,359,666 | 3,170,509 | SH | SOLE | 3,170,509 | 0 | 0 | ||
| CERIBELL INC | COM | 15678C102 | 48,370,146 | 2,205,661 | SH | SOLE | 2,205,661 | 0 | 0 | ||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 7,294,146 | 638,158 | SH | SOLE | 638,158 | 0 | 0 | ||